Hydrazine Sulfate

Chemical promoted for cancer cachexia and as a metabolic anticancer agent that may interfere with tumor glucose use. Hydrazine sulfate has been studied for cancer and cancer-related cachexia. NCI PDQ states randomized trials did not show tumor shrinkage, cachexia results are inconclusive, animal studies suggest carcinogenicity, and FDA has not approved it for cancer treatment.